1 Angiotensin II Receptor Blockers Market Overview 1.1 Angiotensin II Receptor Blockers Product Overview 1.2 Angiotensin II Receptor Blockers Market Segment by Type 1.2.1 Azilsartan 1.2.2 Candesartan 1.2.3 Eprosartan 1.2.4 Irbesartan 1.2.5 Losartan 1.2.6 Olmesartan 1.2.7 Telmisartan 1.2.8 Valsartan 1.3 Global Angiotensin II Receptor Blockers Market Size by Type (2015-2026) 1.3.1 Global Angiotensin II Receptor Blockers Market Size Overview by Type (2015-2026) 1.3.2 Global Angiotensin II Receptor Blockers Historic Market Size Review by Type (2015-2020) 1.3.2.1 Global Angiotensin II Receptor Blockers Sales Market Share Breakdown by Type (2015-2020) 1.3.2.2 Global Angiotensin II Receptor Blockers Revenue Market Share Breakdown by Type (2015-2020) 1.3.2.3 Global Angiotensin II Receptor Blockers Average Selling Price (ASP) by Type (2015-2020) 1.3.3 Global Angiotensin II Receptor Blockers Market Size Forecast by Type (2021-2026) 1.3.3.1 Global Angiotensin II Receptor Blockers Sales Market Share Breakdown by Type (2021-2026) 1.3.3.2 Global Angiotensin II Receptor Blockers Revenue Market Share Breakdown by Type (2021-2026) 1.3.3.3 Global Angiotensin II Receptor Blockers Average Selling Price (ASP) by Type (2021-2026) 1.4 Key Regions Market Size Segment by Type (2015-2020) 1.4.1 North America Angiotensin II Receptor Blockers Sales Breakdown by Type (2015-2020) 1.4.2 Europe Angiotensin II Receptor Blockers Sales Breakdown by Type (2015-2020) 1.4.3 Asia-Pacific Angiotensin II Receptor Blockers Sales Breakdown by Type (2015-2020) 1.4.4 Latin America Angiotensin II Receptor Blockers Sales Breakdown by Type (2015-2020) 1.4.5 Middle East and Africa Angiotensin II Receptor Blockers Sales Breakdown by Type (2015-2020) 2 Global Angiotensin II Receptor Blockers Market Competition by Company 2.1 Global Top Players by Angiotensin II Receptor Blockers Sales (2015-2020) 2.2 Global Top Players by Angiotensin II Receptor Blockers Revenue (2015-2020) 2.3 Global Top Players Angiotensin II Receptor Blockers Average Selling Price (ASP) (2015-2020) 2.4 Global Top Manufacturers Angiotensin II Receptor Blockers Manufacturing Base Distribution, Sales Area, Product Type 2.5 Angiotensin II Receptor Blockers Market Competitive Situation and Trends 2.5.1 Angiotensin II Receptor Blockers Market Concentration Rate (2015-2020) 2.5.2 Global 5 and 10 Largest Manufacturers by Angiotensin II Receptor Blockers Sales and Revenue in 2019 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin II Receptor Blockers as of 2019) 2.7 Date of Key Manufacturers Enter into Angiotensin II Receptor Blockers Market 2.8 Key Manufacturers Angiotensin II Receptor Blockers Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Global Angiotensin II Receptor Blockers by Region (2015-2026) 3.1 Global Angiotensin II Receptor Blockers Market Size and CAGR by Region: 2015 VS 2020 VS 2026 3.2 Global Angiotensin II Receptor Blockers Market Size Market Share by Region (2015-2020) 3.2.1 Global Angiotensin II Receptor Blockers Sales Market Share by Region (2015-2020) 3.2.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Region (2015-2020) 3.2.3 Global Angiotensin II Receptor Blockers Sales, Revenue, Price and Gross Margin (2015-2020) 3.3 Global Angiotensin II Receptor Blockers Market Size Market Share by Region (2021-2026) 3.3.1 Global Angiotensin II Receptor Blockers Sales Market Share by Region (2021-2026) 3.3.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Region (2021-2026) 3.3.3 Global Angiotensin II Receptor Blockers Sales, Revenue, Price and Gross Margin (2021-2026) 4 Global Angiotensin II Receptor Blockers by Application 4.1 Angiotensin II Receptor Blockers Segment by Application 4.1.1 Chronic Kidney Diseases 4.1.2 Heart Failure 4.1.3 Kidney Failure in Diabetes 4.2 Global Angiotensin II Receptor Blockers Sales by Application: 2015 VS 2020 VS 2026 4.3 Global Angiotensin II Receptor Blockers Historic Sales by Application (2015-2020) 4.4 Global Angiotensin II Receptor Blockers Forecasted Sales by Application (2021-2026) 4.5 Key Regions Angiotensin II Receptor Blockers Market Size by Application 4.5.1 North America Angiotensin II Receptor Blockers by Application 4.5.2 Europe Angiotensin II Receptor Blockers by Application 4.5.3 Asia-Pacific Angiotensin II Receptor Blockers by Application 4.5.4 Latin America Angiotensin II Receptor Blockers by Application 4.5.5 Middle East and Africa Angiotensin II Receptor Blockers by Application 5 North America Angiotensin II Receptor Blockers Market Size by Country (2015-2026) 5.1 North America Market Size Market Share by Country (2015-2020) 5.1.1 North America Angiotensin II Receptor Blockers Sales Market Share by Country (2015-2020) 5.1.2 North America Angiotensin II Receptor Blockers Revenue Market Share by Country (2015-2020) 5.2 North America Market Size Market Share by Country (2021-2026) 5.2.1 North America Angiotensin II Receptor Blockers Sales Market Share by Country (2021-2026) 5.2.2 North America Angiotensin II Receptor Blockers Revenue Market Share by Country (2021-2026) 6 Europe Angiotensin II Receptor Blockers Market Size by Country (2015-2026) 6.1 Europe Market Size Market Share by Country (2015-2020) 6.1.1 Europe Angiotensin II Receptor Blockers Sales Market Share by Country (2015-2020) 6.1.2 Europe Angiotensin II Receptor Blockers Revenue Market Share by Country (2015-2020) 6.2 Europe Market Size Market Share by Country (2021-2026) 6.2.1 Europe Angiotensin II Receptor Blockers Sales Market Share by Country (2021-2026) 6.2.2 Europe Angiotensin II Receptor Blockers Revenue Market Share by Country (2021-2026) 7 Asia-Pacific Angiotensin II Receptor Blockers Market Size by Region (2015-2026) 7.1 Asia-Pacific Market Size Market Share by Region (2015-2020) 7.1.1 Asia-Pacific Angiotensin II Receptor Blockers Sales Market Share by Region (2015-2020) 7.1.2 Asia-Pacific Angiotensin II Receptor Blockers Revenue Market Share by Region (2015-2020) 7.2 Asia-Pacific Market Size Market Share by Region (2021-2026) 7.2.1 Asia-Pacific Angiotensin II Receptor Blockers Sales Market Share by Region (2021-2026) 7.2.2 Asia-Pacific Angiotensin II Receptor Blockers Revenue Market Share by Region (2021-2026) 8 Latin America Angiotensin II Receptor Blockers Market Size by Country (2015-2026) 8.1 Latin America Market Size Market Share by Country (2015-2020) 8.1.1 Latin America Angiotensin II Receptor Blockers Sales Market Share by Country (2015-2020) 8.1.2 Latin America Angiotensin II Receptor Blockers Revenue Market Share by Country (2015-2020) 8.2 Latin America Market Size Market Share by Country (2021-2026) 8.2.1 Latin America Angiotensin II Receptor Blockers Sales Market Share by Country (2021-2026) 8.2.2 Latin America Angiotensin II Receptor Blockers Revenue Market Share by Country (2021-2026) 9 Middle East and Africa Angiotensin II Receptor Blockers Market Size by Country (2015-2026) 9.1 Middle East and Africa Market Size Market Share by Country (2015-2020) 9.1.1 Middle East and Africa Angiotensin II Receptor Blockers Sales Market Share by Country (2015-2020) 9.1.2 Middle East and Africa Angiotensin II Receptor Blockers Revenue Market Share by Country (2015-2020) 9.2 Middle East and Africa Market Size Market Share by Country (2021-2026) 9.2.1 Middle East and Africa Angiotensin II Receptor Blockers Sales Market Share by Country (2021-2026) 9.2.2 Middle East and Africa Angiotensin II Receptor Blockers Revenue Market Share by Country (2021-2026) 10 Company Profiles and Key Figures in Angiotensin II Receptor Blockers Business 10.1 Merck & Co. 10.1.1 Merck & Co. Corporation Information 10.1.2 Merck & Co. Description, Business Overview 10.1.3 Merck & Co. Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2015-2020) 10.1.4 Merck & Co. Angiotensin II Receptor Blockers Products Offered 10.1.5 Merck & Co. Recent Developments 10.2 AstraZeneca 10.2.1 AstraZeneca Corporation Information 10.2.2 AstraZeneca Description, Business Overview 10.2.3 AstraZeneca Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2015-2020) 10.2.4 Merck & Co. Angiotensin II Receptor Blockers Products Offered 10.2.5 AstraZeneca Recent Developments 10.3 Novartis 10.3.1 Novartis Corporation Information 10.3.2 Novartis Description, Business Overview 10.3.3 Novartis Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2015-2020) 10.3.4 Novartis Angiotensin II Receptor Blockers Products Offered 10.3.5 Novartis Recent Developments 10.4 Teva 10.4.1 Teva Corporation Information 10.4.2 Teva Description, Business Overview 10.4.3 Teva Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2015-2020) 10.4.4 Teva Angiotensin II Receptor Blockers Products Offered 10.4.5 Teva Recent Developments 10.5 Bayer 10.5.1 Bayer Corporation Information 10.5.2 Bayer Description, Business Overview 10.5.3 Bayer Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2015-2020) 10.5.4 Bayer Angiotensin II Receptor Blockers Products Offered 10.5.5 Bayer Recent Developments 10.6 GlaxoSmithKline 10.6.1 GlaxoSmithKline Corporation Information 10.6.2 GlaxoSmithKline Description, Business Overview 10.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2015-2020) 10.6.4 GlaxoSmithKline Angiotensin II Receptor Blockers Products Offered 10.6.5 GlaxoSmithKline Recent Developments 10.7 Sun Pharmaceutical 10.7.1 Sun Pharmaceutical Corporation Information 10.7.2 Sun Pharmaceutical Description, Business Overview 10.7.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2015-2020) 10.7.4 Sun Pharmaceutical Angiotensin II Receptor Blockers Products Offered 10.7.5 Sun Pharmaceutical Recent Developments 10.8 Mylan 10.8.1 Mylan Corporation Information 10.8.2 Mylan Description, Business Overview 10.8.3 Mylan Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2015-2020) 10.8.4 Mylan Angiotensin II Receptor Blockers Products Offered 10.8.5 Mylan Recent Developments 11 Angiotensin II Receptor Blockers Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Angiotensin II Receptor Blockers Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Angiotensin II Receptor Blockers Industrial Chain Analysis 11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis 11.4.1 Angiotensin II Receptor Blockers Industry Trends 11.4.2 Angiotensin II Receptor Blockers Market Drivers 11.4.3 Angiotensin II Receptor Blockers Market Challenges 11.4.4 Porter’s Five Forces Analysis 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Distributors 12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Author Details 14.4 Disclaimer

List of Tables Table 1. Major Players of Azilsartan Table 2. Major Players of Candesartan Table 3. Major Players of Eprosartan Table 4. Major Players of Irbesartan Table 5. Major Players of Losartan Table 6. Major Players of Olmesartan Table 7. Major Players of Telmisartan Table 8. Major Players of Valsartan Table 9. Global Angiotensin II Receptor Blockers Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million) Table 10. Global Angiotensin II Receptor Blockers Sales (K Units) by Type (2015-2020) (K Units) Table 11. Global Angiotensin II Receptor Blockers Sales Share by Type (2015-2020) Table 12. Global Angiotensin II Receptor Blockers Revenue (Million USD) by Type (2015-2020) Table 13. Global Angiotensin II Receptor Blockers Revenue Share by Type (2015-2020) Table 14. Global Angiotensin II Receptor Blockers Average Selling Price (ASP) (USD/Unit) by Type (2015-2020) Table 15. Global Angiotensin II Receptor Blockers Sales by Type (2021-2026) (K Units) Table 16. Global Angiotensin II Receptor Blockers Sales Share by Type (2021-2026) Table 17. Global Angiotensin II Receptor Blockers Revenue (US$ Million) by Type (2021-2026) Table 18. Global Angiotensin II Receptor Blockers Revenue Share by Type (2021-2026) Table 19. Global Angiotensin II Receptor Blockers Average Selling Price (ASP) (USD/Unit) by Type (2021-2026) Table 20. North America Angiotensin II Receptor Blockers Sales (USD/Unit) by Type (2015-2020) Table 21. Europe Angiotensin II Receptor Blockers Sales (USD/Unit) by Type (2015-2020) Table 22. Asia-Pacific Angiotensin II Receptor Blockers Sales (USD/Unit) by Type (2015-2020) Table 23. Latin America Angiotensin II Receptor Blockers Sales (USD/Unit) by Type (2015-2020) Table 24. Middle East and Africa Angiotensin II Receptor Blockers Sales (USD/Unit) by Type (2015-2020) Table 25. Global Angiotensin II Receptor Blockers Sales (K Units) by Company (2015-2020) Table 26. Global Angiotensin II Receptor Blockers Sales Share by Company (2015-2020) Table 27. Global Angiotensin II Receptor Blockers Revenue (Million US$) by Company (2015-2020) Table 28. Global Angiotensin II Receptor Blockers Revenue Share by Company (2015-2020) Table 29. Global Market Angiotensin II Receptor Blockers Average Selling Price (USD/Unit) by Company (2015-2020) Table 30. Global Angiotensin II Receptor Blockers Top Manufacturers Manufacturing Base Distribution and Sales Area Table 31. Global Angiotensin II Receptor Blockers Top Manufacturers Product Category Table 32. Global Angiotensin II Receptor Blockers Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiotensin II Receptor Blockers as of 2019 Table 34. Date of Key Manufacturers Enter into Angiotensin II Receptor Blockers Market Table 35. Key Manufacturers Angiotensin II Receptor Blockers Product Type Table 36. Mergers & Acquisitions, Expansion Plans Table 37. Global Angiotensin II Receptor Blockers Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026 Table 38. Global Angiotensin II Receptor Blockers Sales (K Units) by Region (2015-2020) Table 39. Global Angiotensin II Receptor Blockers Sales Market Share by Region (2015-2020) Table 40. Global Angiotensin II Receptor Blockers Revenue (US$ Million) by Region (2015-2020) Table 41. Global Angiotensin II Receptor Blockers Revenue Market Share by Region (2015-2020) Table 42. Global Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020) Table 43. Global Angiotensin II Receptor Blockers Sales (K Units) by Region (2021-2026) Table 44. Global Angiotensin II Receptor Blockers Sales Market Share by Region (2021-2026) Table 45. Global Angiotensin II Receptor Blockers Revenue (US$ Million) by Region (2021-2026) Table 46. Global Angiotensin II Receptor Blockers Revenue Market Share by Region (2021-2026) Table 47. Global Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 48. Global Angiotensin II Receptor Blockers Sales (K Units) by Application: 2015 VS 2020 VS 2026 Table 49. Global Angiotensin II Receptor Blockers Sales (K Units) by Application (2015-2020) Table 50. Global Angiotensin II Receptor Blockers Sales Share by Application (2015-2020) Table 51. Global Angiotensin II Receptor Blockers Sales (K Units) by Application (2021-2026) Table 52. Global Angiotensin II Receptor Blockers Sales Share by Application (2021-2026) Table 53. North America Angiotensin II Receptor Blockers Sales (K Units) by Application (2015-2020) Table 54. North America Sales Angiotensin II Receptor Blockers Market Share by Application (2015-2020) Table 55. Europe Angiotensin II Receptor Blockers Sales (K Units) by Application (2015-2020) Table 56. Europe Sales Angiotensin II Receptor Blockers Market Share by Application In 2019 Table 57. Asia-Pacific Angiotensin II Receptor Blockers Sales (K Units) by Application (2015-2020) Table 58. Asia-Pacific Sales Angiotensin II Receptor Blockers Market Share by Application In 2019 Table 59. Latin America Angiotensin II Receptor Blockers Sales (K Units) by Application (2015-2020) Table 60. Latin America Sales Angiotensin II Receptor Blockers Market Share by Application In 2019 Table 61. Middle East and Africa Angiotensin II Receptor Blockers Sales (K Units) by Application (2015-2020) Table 62. Middle East and Africa Angiotensin II Receptor Blockers Sales Share by Application (2015-2020) Table 63. North America Angiotensin II Receptor Blockers Sales (K Units) by Country (2015-2020) Table 64. North America Angiotensin II Receptor Blockers Sales Market Share by Country (2015-2020) Table 65. North America Angiotensin II Receptor Blockers Revenue (US$ Million) by Country (2015-2020) Table 66. North America Angiotensin II Receptor Blockers Revenue Market Share by Country (2015-2020) Table 67. North America Angiotensin II Receptor Blockers Sales (K Units) by Country (2021-2026) Table 68. North America Angiotensin II Receptor Blockers Sales Market Share by Country (2021-2026) Table 69. North America Angiotensin II Receptor Blockers Revenue (US$ Million) by Country (2021-2026) Table 70. North America Angiotensin II Receptor Blockers Revenue Market Share by Country (2021-2026) Table 71. Europe Angiotensin II Receptor Blockers Sales (K Units) by Country (2015-2020) Table 72. Europe Angiotensin II Receptor Blockers Sales Market Share by Country (2015-2020) Table 73. Europe Angiotensin II Receptor Blockers Revenue (US$ Million) by Country (2015-2020) Table 74. Europe Angiotensin II Receptor Blockers Revenue Market Share by Country (2015-2020) Table 75. Europe Angiotensin II Receptor Blockers Sales (K Units) by Country (2021-2026) Table 76. Europe Angiotensin II Receptor Blockers Sales Market Share by Country (2021-2026) Table 77. Europe Angiotensin II Receptor Blockers Revenue (US$ Million) by Country (2021-2026) Table 78. Europe Angiotensin II Receptor Blockers Revenue Market Share by Country (2021-2026) Table 79. Asia-Pacific Angiotensin II Receptor Blockers Sales (K Units) by Region (2015-2020) Table 80. Asia-Pacific Angiotensin II Receptor Blockers Sales Market Share by Region (2015-2020) Table 81. Asia-Pacific Angiotensin II Receptor Blockers Revenue (US$ Million) by Region (2015-2020) Table 82. Asia-Pacific Angiotensin II Receptor Blockers Revenue Market Share by Region (2015-2020) Table 83. Asia-Pacific Angiotensin II Receptor Blockers Sales (K Units) by Region (2021-2026) Table 84. Asia-Pacific Angiotensin II Receptor Blockers Sales Market Share by Region (2021-2026) Table 85. Asia-Pacific Angiotensin II Receptor Blockers Revenue (US$ Million) by Region (2021-2026) Table 86. Asia-Pacific Angiotensin II Receptor Blockers Revenue Market Share by Region (2021-2026) Table 87. Latin America Angiotensin II Receptor Blockers Sales (K Units) by Country (2015-2020) Table 88. Latin America Angiotensin II Receptor Blockers Sales Market Share by Country (2015-2020) Table 89. Latin America Angiotensin II Receptor Blockers Revenue (US$ Million) by Country (2015-2020) Table 90. Latin America Angiotensin II Receptor Blockers Revenue Market Share by Country (2015-2020) Table 91. Latin America Angiotensin II Receptor Blockers Sales (K Units) by Country (2021-2026) Table 92. Latin America Angiotensin II Receptor Blockers Sales Market Share by Country (2021-2026) Table 93. Latin America Angiotensin II Receptor Blockers Revenue (US$ Million) by Country (2021-2026) Table 94. Latin America Angiotensin II Receptor Blockers Revenue Market Share by Country (2021-2026) Table 95. Middle East and Africa Angiotensin II Receptor Blockers Sales (K Units) by Country (2015-2020) Table 96. Middle East and Africa Angiotensin II Receptor Blockers Sales Market Share by Country (2015-2020) Table 97. Middle East and Africa Angiotensin II Receptor Blockers Revenue (US$ Million) by Country (2015-2020) Table 98. Middle East and Africa Angiotensin II Receptor Blockers Revenue Market Share by Country (2015-2020) Table 99. Middle East and Africa Angiotensin II Receptor Blockers Sales (K Units) by Country (2021-2026) Table 100. Middle East and Africa Angiotensin II Receptor Blockers Sales Market Share by Country (2021-2026) Table 101. Middle East and Africa Angiotensin II Receptor Blockers Revenue (US$ Million) by Country (2021-2026) Table 102. Middle East and Africa Angiotensin II Receptor Blockers Revenue Market Share by Country (2021-2026) Table 103. Merck & Co. Corporation Information Table 104. Merck & Co. Description and Business Overview Table 105. Merck & Co. Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 106. Merck & Co. Angiotensin II Receptor Blockers Product Table 107. Merck & Co. Recent Developments Table 108. AstraZeneca Corporation Information Table 109. AstraZeneca Description and Business Overview Table 110. AstraZeneca Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 111. AstraZeneca Angiotensin II Receptor Blockers Product Table 112. AstraZeneca Recent Developments Table 113. Novartis Corporation Information Table 114. Novartis Description and Business Overview Table 115. Novartis Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 116. Novartis Angiotensin II Receptor Blockers Product Table 117. Novartis Recent Developments Table 118. Teva Corporation Information Table 119. Teva Description and Business Overview Table 120. Teva Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 121. Teva Angiotensin II Receptor Blockers Product Table 122. Teva Recent Developments Table 123. Bayer Corporation Information Table 124. Bayer Description and Business Overview Table 125. Bayer Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 126. Bayer Angiotensin II Receptor Blockers Product Table 127. Bayer Recent Developments Table 128. GlaxoSmithKline Corporation Information Table 129. GlaxoSmithKline Description and Business Overview Table 130. GlaxoSmithKline Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 131. GlaxoSmithKline Angiotensin II Receptor Blockers Product Table 132. GlaxoSmithKline Recent Developments Table 133. Sun Pharmaceutical Corporation Information Table 134. Sun Pharmaceutical Description and Business Overview Table 135. Sun Pharmaceutical Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 136. Sun Pharmaceutical Angiotensin II Receptor Blockers Product Table 137. Sun Pharmaceutical Recent Developments Table 138. Mylan Corporation Information Table 139. Mylan Description and Business Overview Table 140. Mylan Angiotensin II Receptor Blockers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020) Table 141. Mylan Angiotensin II Receptor Blockers Product Table 142. Mylan Recent Developments Table 143. Key Raw Materials Lists Table 144. Raw Materials Key Suppliers Lists Table 145. Angiotensin II Receptor Blockers Opportunities and Drivers Table 146. Angiotensin II Receptor Blockers Market Challenges Table 147. Angiotensin II Receptor Blockers Market Risks Table 148. Distributors List Table 149. Angiotensin II Receptor Blockers Downstream Customers Table 150. Research Programs/Design for This Report Table 151. Key Data Information from Secondary Sources Table 152. Key Data Information from Primary Sources List of Figures Figure 1. Angiotensin II Receptor Blockers Product Picture Figure 2. Global Angiotensin II Receptor Blockers Market Size (Value), (illion USD), 2015 VS 2020 VS 2026 Figure 3. Global Angiotensin II Receptor Blockers Revenue (Million USD) Status and Outlook (2015-2026) Figure 4. Global Angiotensin II Receptor Blockers Sales (K Units) Status and Outlook (2015-2026) Figure 5. Product Picture of Azilsartan Figure 6. Global Azilsartan Sales (K Units): YoY Growth (2015-2020) Figure 7. Product Picture of Candesartan Figure 8. Global Candesartan Sales (K Units): YoY Growth (2015-2020) Figure 9. Product Picture of Eprosartan Figure 10. Global Eprosartan Sales (K Units): YoY Growth (2015-2020) Figure 11. Product Picture of Irbesartan Figure 12. Global Irbesartan Sales (K Units): YoY Growth (2015-2020) Figure 13. Product Picture of Losartan Figure 14. Global Losartan Sales (K Units): YoY Growth (2015-2020) Figure 15. Product Picture of Olmesartan Figure 16. Global Olmesartan Sales (K Units): YoY Growth (2015-2020) Figure 17. Product Picture of Telmisartan Figure 18. Global Telmisartan Sales (K Units): YoY Growth (2015-2020) Figure 19. Product Picture of Valsartan Figure 20. Global Valsartan Sales (K Units): YoY Growth (2015-2020) Figure 21. Global Angiotensin II Receptor Blockers Revenue and Growth Rate by Type (US$ Million) (2015-2026) Figure 22. Global Angiotensin II Receptor Blockers Sales Market Share by Type in 2019 Figure 23. Global Angiotensin II Receptor Blockers Revenue Share by Type (2015-2020) Figure 24. Global Angiotensin II Receptor Blockers Revenue Market Share by Type in 2019 Figure 25. Global Angiotensin II Receptor Blockers Sales Market Share by Type (2021-2026) Figure 26. Global Angiotensin II Receptor Blockers Sales Market Share by Type In 2019 Figure 27. Global Angiotensin II Receptor Blockers Revenue Share by Type (2021-2026) Figure 28. Global Angiotensin II Receptor Blockers Revenue Market Share by Type In 2019 Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Angiotensin II Receptor Blockers Sales in 2019 Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Angiotensin II Receptor Blockers Revenue in 2019 Figure 31. Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 33. Chronic Kidney Diseases Examples Figure 34. Heart Failure Examples Figure 35. Kidney Failure in Diabetes Examples Figure 36. Key Raw Materials Price Figure 37. Angiotensin II Receptor Blockers Manufacturing Cost Structure Figure 38. Angiotensin II Receptor Blockers Industrial Chain Analysis Figure 39. Porter's Five Forces Analysis Figure 40. Channels of Distribution Figure 41. Distributors Profiles Figure 42. Bottom-up and Top-down Approaches for This Report Figure 43. Data Triangulation Figure 44. Key Executives Interviewed

Merck & Co. AstraZeneca Novartis Teva Bayer GlaxoSmithKline Sun Pharmaceutical Mylan